-
Aclaris aquires Vixen (JAK inhibitor research)
One article here. Aclaris is a NASDAQ traded company with an estimated value of $55M and an estimated market cap of $350M.
Edit: Basically a repost, can't find a way to delete.
Similar Threads
-
By sksingh91 in forum Hair Loss Treatments
Replies: 58
Last Post: 02-07-2018, 02:19 AM
-
By candu2015 in forum Cutting Edge / Future Treatments
Replies: 9
Last Post: 04-03-2016, 10:40 AM
-
By Tenma in forum Techniques in Possible Donor Regeneration and Multiplication
Replies: 2
Last Post: 10-05-2015, 10:02 AM
-
By lacazette in forum Hair Loss Treatments
Replies: 3
Last Post: 06-22-2015, 09:30 AM
-
By goldnt in forum Men's Hair Loss: Start Your Own Topic
Replies: 0
Last Post: 09-13-2014, 07:22 PM
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules
|
» IAHRS
» The Bald Truth
» americanhairloss.org
|
Bookmarks